Found: 2
Select item for more details and to access through your institution.
Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.
- Published in:
- Lipids in Health & Disease, 2016, v. 15, p. 1, doi. 10.1186/s12944-016-0182-y
- By:
- Publication type:
- Article
Diversity of Apolipoprotein E genetic polymorphism significance on cardiovascular risk is determined by the presence of Metabolic Syndrome among hypertensive patients.
- Published in:
- Lipids in Health & Disease, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-511X-13-174
- By:
- Publication type:
- Article